<DOC>
	<DOCNO>NCT01283932</DOCNO>
	<brief_summary>To compare single dose bioavailability pantoprazole sodium 40 mg delay release tablet ( Dr. Reddy 's Laboratories Ltd , India ) Protonix® 40 mg delay release tablet ( Wyeth Laboratories , USA ) 52 ( + 6 standby ) healthy , adult , human subject fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Pantoprazole Sodium DR Tablets 40 mg Dr. Reddy 's Laboratories Limited Under Fed Condition</brief_title>
	<detailed_description>This Open label , balance , randomize two-treatment , two-period , two-sequence , crossover bioequivalence study least 07 day washout period drug administration feed conditions.52 ( +6 standby ) healthy , adult , human subject enrol . A single oral dose 40 mg pantoprazole delay release tablet administer along 240 mL drink water within 30 minute serve high fat breakfast .</detailed_description>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>1 . Subjects provide write informed consent . 2 . Subjects must healthy human being within 1845 year age ( inclusive ) weigh least 50 kg . 3 . Subjects must within ±10 % ideal body weight relation height accord Life Insurance Corporation India heightweight chart nonmedical case . 4 . Subjects must normal health determine medical history physical examination perform within 15 day prior commencement study . 5 . Have normal EcG , Xray vital sign . 6 . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . 7 . If subject female volunteer 1 . Is child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . 2. postmenopausal least 1 year . 3. surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) 1 . Subjects incapable understanding informed consent . 2 . Subjects BP≤90/60 BP≥140/90 3 . History hypersensitivity idiosyncratic reaction pantoprazole proton pump inhibitor . 4 . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . 5 . Regular smoker smoke ten cigarette daily difficulty abstain smoke duration study period . 6 . Subjects take counter prescribed medication , include enzyme modifying drug systemic medication within past 30 day prior start clinical period . 7 . History psychiatric illness , may impair ability provide write , informed consent . 8 . Subjects history alcohol substance abuse within last 5 year . 9 . Subjects clinically significant abnormal value laboratory parameter . 10 . Subjects participate clinical investigation use experimental drug bleed 350 mL past 3 month . 11 . Subjects positive urine screen drug abuse . 12 . Any subject pantoprazole contraindicate medical reason . 13 . Female volunteer demonstrate positive pregnancy screen . 14 . Female volunteer currently breastfeed .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>